With funding rounds of all sizes and a buzzy new acquisition on the Boston tech front, read more to learn how these companies are growing and bringing their ideas to life. This is the Built In Boston weekly refresh.
PathAI acquired Poplar Healthcare Management. PathAI works to provide pathologists with diagnostic products aimed at supporting patient care. By adding Poplar to its ranks, PathAI hopes to leverage its laboratory and team to build out end-to-end capabilities geared toward developing and delivering new AI-based offerings for drug development and for patient care. [PR Newswire]
DataRobot secured $300M. After a hefty Series G co-led by Altimeter Capital and Tiger Global, DataRobot is expanding its go-to-market team and planning to hire new talent in 150 positions. The company’s AI-powered enterprise software automates the process of building, deploying and managing machine learning models to help companies drive better insights from all their data. It’s currently looking to fill 50 Boston-based roles. [Built In Boston]
Boston Tech Quote of the Week
Embark Vet pulled in $75M. Making sure even the furriest family members are happy and healthy, Embark Vet provides canine DNA testing kits that are capable of scouting out 200 different genetic health risks in 350 different breeds of dogs. With its latest round of funding, it’s planning to fuel product development and hiring across engineering, operations, marketing and more. SoftBank Vision Fund 2 led the Series B. [Built In Boston]
Noetic Cyber got $20M. Offering enterprise security team leaders a cloud-based platform that automates the task of finding problems and highlighting them to be fixed, Noetic Cyber pulled in Series A funding led by Energy Impact Partners. Other participants in this round were existing investors TenEleven Ventures and Glasswing Ventures. [FinSMEs]
